A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
- Sponsor
- Janssen Korea, Ltd., Korea
- Study ID
- NCT07520747
- Status
- Recruiting
Conditions
- Inflammatory Bowel Diseases
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - 17 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is: * to find out out the number of children who develop crohn's disease (CD) and ulcerative colitis (UC) each year and are living with the disease and to see how this differs by age groups. * to understand how children of different age groups are treated over time and how their treatment changes as they grow. * to assess how often children use healthcare services and how much this costs for different age groups over several years. CD and UC are long-term diseases that cause inflammation in intestine (part of digestive system) and develop ulcers.
Key Dates
- First listed
- Apr 9, 2026
- Start date
- Apr 7, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 8,000 participants (estimated)
Arms
- Arm: Group 1: Newly and Previously Diagnosed Pediatric Inflammatory Bowel Disease (IBD) ParticipantsParticipants, who have been either newly diagnosed or previously diagnosed with Crohn's disease (CD) or Ulcerative colitis (UC) will be enrolled. Data will be analyzed for epidemiology, baseline demographics and clinical characteristics, health care resource utilization profiles, and associated costs. Only newly diagnosed participants will be included in the analysis of longitudinal treatment patterns and incidence estimation. Only data available per routine clinical practice will be used in this study and will be de-identified and extracted from the health insurance review and assessment (HIRA) database.
Primary Outcome Measure
Crude and Age-Adjusted Annual Incidence in Pediatric Crohn's Disease (CD) [ Time Frame: During the index period (2012 to 2023; up to 12 years) ]
Central Contacts
- Study Contact844-434-4210
Related Studies
- The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruiting · University of Chicago · Chicago, Illinois
- Improving the Quality of Care for Adults With Inflammatory Bowel DiseaseEnrolling By Invitation · Dartmouth-Hitchcock Medical Center · Los Angeles, California
- CorEvitas Inflammatory Bowel Disease (IBD) RegistryEnrolling By Invitation · CorEvitas · Waltham, Massachusetts
- Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)Enrolling By Invitation · Boston Children's Hospital · Boston, Massachusetts